LINKS
Dive into my extraordinary achievements and influential ventures through a curated collection of high-profile collaborations and noteworthy third-party features. From pioneering the top open-access podcast on Player.FM to leading discussions on post-publication promotion strategies, I have left an indelible mark on the academic and medical communities. Explore their significant contributions, such as launching the Rapamycin Press Medical Blog and being part of esteemed committees like the Career Progression Task Force. Join us on a journey through my impactful endeavors, shedding light on their invaluable insights and expertise in the realm of science and scholarship.
Read an article via Martha Stewart about a recent Aging paper: "Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial" by Dr. Kara Fitzgerald
Ryan James Jessup, Director of External & Legal Affairs at Impact Journals, discusses Oncotarget, a top cancer research journal. Unique for its broad scope, it covers molecules, pathways, and tissues relevant to cancer and other diseases, fostering interdisciplinary research. The podcast stands out in the crowded cancer podcast landscape, maximizing impact through insightful peer-review and linking various oncology fields.
Presentation on Post-publication Promotion “How to Rapidly and Widely Disseminate New Results and Scholarship for Small Publishers”
This is your Project description. Click on "Edit Text" or double click on the text box to start.
Ryan Jessup, Director of External Affairs at Rapamycin Press, talks about launching their medical blog on eHealth Radio. He shares insights into the blog's inspiration, challenges faced, and the content visitors can expect. Jessup's diverse background in law, public affairs, and publishing informs his approach, offering valuable advice to aspiring bloggers.
Ryan Jessup, Director of External Affairs at Rapamycin Press, talks about launching their medical blog on eHealth Radio. He shares insights into the blog's inspiration, challenges faced, and the content visitors can expect. Jessup's diverse background in law, public affairs, and publishing informs his approach, offering valuable advice to aspiring bloggers.
Shaping the New Status Quo: Global Perspectives in Scholarly Publishing - Ryan James Jessup JD/MPA | Post-publication Manuscript Promotion: A Small Publisher’s Ability to Rapidly and Widely Disseminate New Results and Scholarship with In-house Techniques
Ryan Jessup, Director of External Affairs at Rapamycin Press, talks about launching their medical blog on eHealth Radio. He shares insights into the blog's inspiration, challenges faced, and the content visitors can expect. Jessup's diverse background in law, public affairs, and publishing informs his approach, offering valuable advice to aspiring bloggers.
In the digital age, access to information has dramatically increased through platforms like Oncotarget, led by Mikhail Blagosklonny. While it offers immense benefits, the rise of unregulated sources and fake news poses challenges. Maintaining rigorous fact-checking standards is crucial. Reliable sources, like research papers and peer-reviewed journals, are essential. As technology advances, discerning credible information from established platforms becomes vital in this information-rich era.
Oncotarget's peer-reviewed research publications will now be indexed in Meta, enhancing global accessibility and aiding scientists in analysis and research exploration. This partnership, facilitated by the Chan Zuckerberg Initiative, marks a significant step forward for Oncotarget and the scientific community.
This study analyzes Oncotarget's bibliometric structure. Despite losing its impact factor status, it exhibited unique global publishing patterns, emphasizing Chinese articles. The research explores the journal's evolution in the scientific community, crucial for understanding its impact and accessibility
Oncotarget, once considered prolific in oncology research, faced controversies. It was dropped from Medline and delisted by Clarivate Analytics after being recommended as a "Rising Star." The abrupt changes left researchers puzzled, highlighting inconsistencies in evaluating journals.
